Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The evolving picture of lower urinary tract symptom management.

× No keyword cloud information.

8 in total

Review 1. Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.

Authors: Cosimo De Nunzio; Andrea Tubaro
Journal: Nat Rev Urol Date: 2015-01-06 Impact factor: 14.432

Review 2. Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?

Authors: Fabrizio Presicce; Cosimo De Nunzio; Andrea Tubaro
Journal: Curr Urol Rep Date: 2017-09 Impact factor: 3.092

Review 3. Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors: Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal: Nat Rev Urol Date: 2016-09-30 Impact factor: 14.432

Review 4. Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging.

Authors: Dehong Cao; Ruonan Sun; Lei Peng; Jinze Li; Yin Huang; Zeyu Chen; Bo Chen; Jin Li; Jianzhong Ai; Lu Yang; Liangren Liu; Qiang Wei
Journal: Front Immunol Date: 2022-03-21 Impact factor: 7.561

5. Combined treatment with dihydrotestosterone and lipopolysaccharide modulates prostate homeostasis by upregulating TNF-α from M1 macrophages and promotes proliferation of prostate stromal cells.

Authors: Yu Tong; Yi-Jun Guo; Qin Zhang; Hai-Xia Bi; Kai Kai; Ren-Yuan Zhou
Journal: Asian J Androl Date: 2022 Sep-Oct Impact factor: 3.054

The evolving picture of lower urinary tract symptom management.

Review 1. Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.

Review 2. Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?

Review 3. Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Review 4. Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging.

5. Combined treatment with dihydrotestosterone and lipopolysaccharide modulates prostate homeostasis by upregulating TNF-α from M1 macrophages and promotes proliferation of prostate stromal cells.

6. Identification of key genes in benign prostatic hyperplasia using bioinformatics analysis.

Review 7. Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia.

8. Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea.